Status:

UNKNOWN

The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer

Lead Sponsor:

Turku University Hospital

Conditions:

Mammary Ductal Carcinoma

Eligibility:

FEMALE

Brief Summary

The purpose of this study is to determine how MRI changes the treatment and diagnostics of ductal breast cancer. 100 women with newly diagnosed breast cancer will participate the study.

Eligibility Criteria

Inclusion

  • Tumor size less than 2cm
  • Ductal carcinoma unifocal

Exclusion

  • Previous breast cancer

Key Trial Info

Start Date :

February 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT01484704

Start Date

February 1 2011

Last Update

December 2 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University hospital of Turku

Turku, Finland, 20521